Form 8-K - Current report:
SEC Accession No. 0001104659-25-061435
Filing Date
2025-06-23
Accepted
2025-06-23 08:58:46
Documents
17
Period of Report
2025-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518642d1_8k.htm   iXBRL 8-K 43279
2 EXHIBIT 10.1 tm2518642d1_ex10-1.htm EX-10.1 1067853
3 EXHIBIT 10.2 tm2518642d1_ex10-2.htm EX-10.2 100840
4 EXHIBIT 10.3 tm2518642d1_ex10-3.htm EX-10.3 102393
5 EXHIBIT 10.4 tm2518642d1_ex10-4.htm EX-10.4 29720
6 EXHIBIT 99.1 tm2518642d1_ex99-1.htm EX-99.1 33186
  Complete submission text file 0001104659-25-061435.txt   1851777

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20250622.xsd EX-101.SCH 3023
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20250622_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20250622_pre.xml EX-101.PRE 22364
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2518642d1_8k_htm.xml XML 3558
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 251063106
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)